6057-90-5

Basic information

• Product Name: b-Alanine, hydrochloride
• CAS NO: 6057-90-5
• Molecular Formula: C3H7NO2.ClH
• Molecular Weight: 125.555
• Mol File: 6057-90-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: b-Alanine, hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: b-Alanine, hydrochloride(6057-90-5)
• EPA Substance Registry System: b-Alanine, hydrochloride(6057-90-5)

Safety Data

• Hazardous Substances Data: 6057-90-5(Hazardous Substances Data)

Upstream product

• 3303-84-2 3-(tert-butyloxycarbonylamino)propionic acid 
• 141-78-6 ethyl acetate 
• 67-56-1 methanol 
• 24835-08-3 2-nitrobenzylamine hydrochloride 
• 140-88-5 ethyl acrylate 

Downstream Products

• 924-73-2 3-amino-propionic acid ethyl ester 
• 1159074-12-0 3-(3-(4-chloro-2,5-dimethoxyphenyl)thioureido)propanoic acid 
• 1148144-78-8 {4-[(4-{[4-(carboxymethylcarbamoyl)-phenylimino]-methyl}-benzylidene)-amino]-benzoylamino}-propionic acid 
• 871252-98-1 cis-3-(4-{6,6,6-trifluoro-3-[6-(4-trifluoromethyl-phenyl)-pyridin-3-yl]-hex-1-enyl}-benzoylamino)-propionic acid methyl ester 
• 1065079-56-2 N-(3-amino-3-oxopropyl)-6-(3,4-dichlorobenzyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide 
• 4138-35-6 methyl 3-aminopropanoate 
• 4244-84-2 ethyl β-alaninate hydrochloride 
• 144686-15-7 3-(3-Amino-propionyl)-2,2-dimethyl-thiazolidine-4-carboxylic acid cyclohexylamide 
• 3729-19-9 3-Isocyanatopropanoylchlorid 
• 67726-34-5 N-{4-[(2-thioxo-benzothiazol-3-ylmethyl)-amino]-benzoyl}-β-alanine 
• 67726-28-7 N-{4-[(2-oxo-benzooxazol-3-ylmethyl)-amino]-benzoyl}-β-alanine 
• 144686-17-9 3-(3-Amino-propionyl)-2,2,5,5-tetramethyl-thiazolidine-4-carboxylic acid cyclohexylamide 

Relevant articles and documents

Structure-activity relationship studies of 1-(4-chloro-2,5-dimethoxyphenyl) -3-(3-propoxypropyl)thiourea, a non-nucleoside reverse transcriptase inhibitor of human immunodeficiency virus type-1

The reverse transcriptase (RT) of the human immunodeficiency virus type-1 (HIV-1) is still a prime target for drug development due to the continuing need to block drug-resistant RT mutants by new inhibitors. We have previously identified 1-(4-chloro-2,5-dimethoxyphenyl)-3-(3-propoxypropyl)thiourea, compound 1, as a potent RT inhibitor from an available chemical library. Here, we further modified this compound to study structure-activity relationships when replacing various groups in the molecule. Different functional groups were systematically introduced on the aromatic ring and the aliphatic chain of the compound was modified. The effect of these modifications on viral infectivity was then evaluated. The most potent compound found was propyl 4-(amino-N-(4-chloro-2,5-dimethoxyphenyl)methanethioamino)butanoate, 45c, which inhibited infectivity with a calculated IC50 of about 1.1 μM. Docking studies identified potential important interactions between the top scoring ligands and HIV-1 RT, and the predicted relative affinity of the ligands was found to be in agreement with the experimental results.

Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones

Optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]-quinazolin-2-ones and 6-[H]-1,2,3,4-tetrahydropyrimido[2,1-b]-quinazolin-2-ones or the pharmaceutically acceptable salts thereof are compounds useful as blood platelet anti-aggregative and/or antihypertensive and/or bronchodilator agents in mammals, including humans.